Literature DB >> 28244993

The 'anti-hype' vaccine.

Laura DeFrancesco.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28244993     DOI: 10.1038/nbt.3812

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  14 in total

Review 1.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

Review 2.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

3.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

Review 4.  Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.

Authors:  Charles J Russell; Eric A F Simões; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2018-01-11       Impact factor: 2.257

Review 5.  mRNA as a Therapeutics: Understanding mRNA Vaccines.

Authors:  Ferdi Oğuz; Harika Atmaca
Journal:  Adv Pharm Bull       Date:  2021-05-16

6.  A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

Authors:  Jesse H Erasmus; Amit P Khandhar; Jeff Guderian; Brian Granger; Jacob Archer; Michelle Archer; Emily Gage; Jasmine Fuerte-Stone; Elise Larson; Susan Lin; Ryan Kramer; Rhea N Coler; Christopher B Fox; Dan T Stinchcomb; Steven G Reed; Neal Van Hoeven
Journal:  Mol Ther       Date:  2018-08-02       Impact factor: 11.454

Review 7.  Advances in the delivery of RNA therapeutics: from concept to clinical reality.

Authors:  James C Kaczmarek; Piotr S Kowalski; Daniel G Anderson
Journal:  Genome Med       Date:  2017-06-27       Impact factor: 11.117

8.  Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.

Authors:  Nathifa Moyo; Annette B Vogel; Søren Buus; Stephanie Erbar; Edmund G Wee; Ugur Sahin; Tomáš Hanke
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-26       Impact factor: 6.698

Review 9.  Advances in mRNA Vaccines for Infectious Diseases.

Authors:  Cuiling Zhang; Giulietta Maruggi; Hu Shan; Junwei Li
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

10.  Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods.

Authors:  Trevor R F Smith; Katherine Schultheis; Kate E Broderick
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.